Microfluidic encapsulation of nanoparticles in alginate microgels gelled via competitive ligand exchange crosslinking

Efficient delivery of nanometric vectors complexed with nanoparticles at a target tissue without spreading to other tissues is one of the main challenges in gene therapy. One means to overcome this problem is to confine such vectors within microgels that can be placed in a target tissue to be released slowly and locally. Herein, a conventional optical microscope coupled to a common smartphone was employed to monitor the microfluidic production of monodisperse alginate microgels containing nanoparticles as a model for the encapsulation of vectors. Alginate microgels (1.2%) exhibited an average diameter of 125 +/- 3 mu m, which decreased to 106 +/- 5 mu m after encapsulating 30 nm fluorescent nanoparticles. The encapsulation efficiency was 70.9 +/- 18.9%. In a 0.1 M NaCl solution, 55 +/- 5% and 92 +/- 4.7% of nanoparticles were released in 30 minutes and 48 hours, respectively. Microgel topography assessment by atomic force microscopy revealed that incorporation of nanoparticles into the alginate matrix changes the scaffold's interfacial morphology and induces crystallization with the appearance of oriented domains. The high encapsulation rate of nanoparticles, alongside their continuous release of nanoparticles over time, makes these microgels and the production unit a valuable system for vector encapsulation for gene therapy research.

Automated summary

Efficient delivery of nanometric vectors complexed with nanoparticles to target tissues is crucial for gene therapy, and one possible solution is to confine these vectors within microgels for slow and local release. Alginate microgels with high encapsulation efficiency and continuous release of nanoparticles over time are considered valuable for gene therapy research.